NCT00485810View on ClinicalTrials.gov

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

November 30, 2004

Conditions

Schizophrenia

Interventions

DRUG

Olanzapine Hydrochloride

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sapporo

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00485810 - Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia | Biotech Hunter | Biotech Hunter